相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al.
LANCET (2021)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y. Logunov et al.
LANCET (2021)
COVID-19 infection in solid organ transplant recipients after SARS-CoV-2 vaccination
Hani M. Wadei et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas et al.
LANCET (2021)
Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
David Cucchiari et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
William A. Werbel et al.
ANNALS OF INTERNAL MEDICINE (2021)
Occurrence of severe COVID-19 in vaccinated transplant patients
Sophie Caillard et al.
KIDNEY INTERNATIONAL (2021)
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Alberto M. Borobia et al.
LANCET (2021)
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
Joana Barros-Martins et al.
NATURE MEDICINE (2021)
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Nassim Kamar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
Johan Normark et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
David Liebowitz et al.
LANCET INFECTIOUS DISEASES (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?
John S. Tsang et al.
TRENDS IN IMMUNOLOGY (2020)
Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania
Zacchaeus Anywaine et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
Yoichiro Natori et al.
CLINICAL INFECTIOUS DISEASES (2018)
Repeated stimulation of CD4 effector T cells can limit their protective function
DM Jelley-Gibbs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Mechanism of action of donor-specific transfusion in inducing tolerance: Role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation
K Kishimoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
分享论文
